C.R. Bard created the G2 IVC Filter to replace the Recovery, a 1st-generation IVC filter that was linked to a 40% 5.5-year fracture risk. Unfortunately, the G2 has been linked to a 38% 5-year fracture risk.
Studies have linked C.R. Bard's G2® IVC filter with a 38% risk of fracture within 5 years of implantation. The manufacturer is facing over 1,700 lawsuits for selling a defective and dangerous medical device.
C.R. Bard is facing around 1,500 lawsuits over Inferior Vena Cava (IVC) filters. Many involve Bard's 1st or 2nd-generation filters, which studies estimate fracture in 40% of patients within just 5 years.
Vena cava filters are supposed to prevent deadly pulmonary embolisms (blood clots in the lungs). The problem is that thousands of people have been injured or died from serious complications of filters — especially "optional" IVC filters that are never...